ArticleScientific reports2025

Microbiota and short chain fatty acid relationships underlie clinical heterogeneity and identify key microbial targets in irritable bowel syndrome (IBS).

Andrea S Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.